Kilitch Drugs (India) Limited

NSEI:KILITCH Rapport sur les actions

Capitalisation boursière : ₹5.0b

Kilitch Drugs (India) Gestion

Gestion contrôle des critères 3/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

Mukund Mehta

Directeur général

n/a

Rémunération totale

Pourcentage du salaire du PDGn/a
Durée du mandat du directeur général32.5yrs
Propriété du PDG7.1%
Durée moyenne d'occupation des postes de direction2.5yrs
Durée moyenne du mandat des membres du conseil d'administration7.2yrs

Mises à jour récentes de la gestion

Shareholders Would Not Be Objecting To Kilitch Drugs (India) Limited's (NSE:KILITCH) CEO Compensation And Here's Why

Sep 23
Shareholders Would Not Be Objecting To Kilitch Drugs (India) Limited's (NSE:KILITCH) CEO Compensation And Here's Why

Recent updates

Kilitch Drugs (India) Limited (NSE:KILITCH) Not Flying Under The Radar

Jul 23
Kilitch Drugs (India) Limited (NSE:KILITCH) Not Flying Under The Radar

Here's Why Kilitch Drugs (India) (NSE:KILITCH) Can Manage Its Debt Responsibly

Mar 05
Here's Why Kilitch Drugs (India) (NSE:KILITCH) Can Manage Its Debt Responsibly

Kilitch Drugs (India) Limited (NSE:KILITCH) Looks Just Right With A 26% Price Jump

Feb 02
Kilitch Drugs (India) Limited (NSE:KILITCH) Looks Just Right With A 26% Price Jump

We Ran A Stock Scan For Earnings Growth And Kilitch Drugs (India) (NSE:KILITCH) Passed With Ease

Jan 30
We Ran A Stock Scan For Earnings Growth And Kilitch Drugs (India) (NSE:KILITCH) Passed With Ease

Investors Shouldn't Be Too Comfortable With Kilitch Drugs (India)'s (NSE:KILITCH) Earnings

Nov 17
Investors Shouldn't Be Too Comfortable With Kilitch Drugs (India)'s (NSE:KILITCH) Earnings

Shareholders Would Not Be Objecting To Kilitch Drugs (India) Limited's (NSE:KILITCH) CEO Compensation And Here's Why

Sep 23
Shareholders Would Not Be Objecting To Kilitch Drugs (India) Limited's (NSE:KILITCH) CEO Compensation And Here's Why

These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well

Sep 08
These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well

Here's Why Kilitch Drugs (India) (NSE:KILITCH) Has Caught The Eye Of Investors

May 05
Here's Why Kilitch Drugs (India) (NSE:KILITCH) Has Caught The Eye Of Investors

Kilitch Drugs (India) (NSE:KILITCH) Could Easily Take On More Debt

Jul 06
Kilitch Drugs (India) (NSE:KILITCH) Could Easily Take On More Debt

Here's Why I Think Kilitch Drugs (India) (NSE:KILITCH) Might Deserve Your Attention Today

Apr 08
Here's Why I Think Kilitch Drugs (India) (NSE:KILITCH) Might Deserve Your Attention Today

These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well

Dec 17
These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well

Is Kilitch Drugs (India) (NSE:KILITCH) Using Too Much Debt?

Mar 21
Is Kilitch Drugs (India) (NSE:KILITCH) Using Too Much Debt?

Should Weakness in Kilitch Drugs (India) Limited's (NSE:KILITCH) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Feb 13
Should Weakness in Kilitch Drugs (India) Limited's (NSE:KILITCH) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Is Kilitch Drugs (India) (NSE:KILITCH) Weighed On By Its Debt Load?

Dec 03
Is Kilitch Drugs (India) (NSE:KILITCH) Weighed On By Its Debt Load?

Does Kilitch Drugs (India) Limited (NSE:KILITCH) Have A Place In Your Dividend Stock Portfolio?

Aug 20
Does Kilitch Drugs (India) Limited (NSE:KILITCH) Have A Place In Your Dividend Stock Portfolio?

Should Weakness in Kilitch Drugs (India) Limited's (NSE:KILITCH) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Jul 16
Should Weakness in Kilitch Drugs (India) Limited's (NSE:KILITCH) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Analyse de la rémunération des PDG

Comment la rémunération de Mukund Mehta a-t-elle évolué par rapport aux bénéfices de Kilitch Drugs (India)?
DateRémunération totaleSalaireBénéfices de l'entreprise
Sep 30 2024n/an/a

₹165m

Jun 30 2024n/an/a

₹126m

Mar 31 2024n/an/a

₹146m

Dec 31 2023n/an/a

₹146m

Sep 30 2023n/an/a

₹140m

Jun 30 2023n/an/a

₹117m

Mar 31 2023₹6m₹6m

₹104m

Dec 31 2022n/an/a

₹98m

Sep 30 2022n/an/a

₹85m

Jun 30 2022n/an/a

₹83m

Mar 31 2022₹6m₹6m

₹74m

Dec 31 2021n/an/a

₹52m

Sep 30 2021n/an/a

₹63m

Jun 30 2021n/an/a

₹62m

Mar 31 2021₹6mn/a

₹37m

Dec 31 2020n/an/a

₹17m

Sep 30 2020n/an/a

₹4m

Jun 30 2020n/an/a

-₹3m

Mar 31 2020₹6mn/a

₹8m

Rémunération vs marché: Données insuffisantes pour établir si la rémunération totale de Mukund est raisonnable par rapport à des entreprises de taille similaire sur le marché Indian.

Rémunération et revenus: La rémunération de Mukund a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.


PDG

Mukund Mehta (71 yo)

32.5yrs

Titularisation

₹6,000,000

Compensation

Mr. Mukund Prataprai Mehta, B.Com, LL B., serves as the Chairman and Managing Director at Kilitch Drugs (India) Limited and has been its Executive Director since May 12, 1992. Mr. Mehta served as the Compl...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Mukund Mehta
Executive Chairman & MDno data₹6.00m7.09%
₹ 355.8m
Mira Mehta
Managing Directorless than a year₹2.40m5.23%
₹ 262.4m
Bhavin Mehta
Whole-time Directorno data₹8.40m15.69%
₹ 787.1m
Sunil Jain
Chief Financial Officer3.7yrs₹1.50mpas de données
Tajouddin Ansari
VP-Marketing & Operationno datapas de donnéespas de données
Rajesh Khatri
General Manager - Administrationno datapas de donnéespas de données
Pushpa Nyoupane
Company Secretary & Compliance Officer2.5yrspas de donnéespas de données

2.5yrs

Durée moyenne de l'emploi

48yo

Âge moyen

Gestion expérimentée: L'équipe de direction de KILITCH est considérée comme expérimentée (ancienneté moyenne 2.5 ans).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Mukund Mehta
Executive Chairman & MD32.5yrs₹6.00m7.09%
₹ 355.8m
Mira Mehta
Managing Director10yrs₹2.40m5.23%
₹ 262.4m
Bhavin Mehta
Whole-time Director7.2yrs₹8.40m15.69%
₹ 787.1m
Hemang Engineer
Independent & Non Executive Director16.4yrs₹25.00kpas de données
Vasudev Murti
Non-Executive Independent Director6.7yrs₹30.00kpas de données
Venkita Rajan
Independent Non-Executive Director6.4yrs₹5.00kpas de données
Dipen Jain
Non- Executive Independent Directorless than a yearpas de donnéespas de données

7.2yrs

Durée moyenne de l'emploi

65yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de KILITCH sont considérés comme expérimentés (ancienneté moyenne 7.2 ans).